Allogene Therapeutics Inc
ALLO
Market Cap$514.27M
Close$
$-0.08
102.8% downside
Current Fair Value
102.8% downsideOvervalued by 102.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $514.27 Million |
|---|---|
| Enterprise Value | $218.32 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.8 |
| Beta | 1.85 |
| Outstanding Shares | 170,853,379 |
| Avg 30 Day Volume | 2,203,757 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.75 |
|---|---|
| PEG | 5.13 |
| Price to Sales | - |
| Price to Book Ratio | 1.39 |
| Enterprise Value to Revenue | 3358.84 |
| Enterprise Value to EBIT | -0.77 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.41 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
ESG Score
No data